Status: Recruiting
Study of EVO756 in Adults With Migraine
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
Participants needed: 330
Trial details
Phase: Phase 2Age: 18-64Biological sex: AllType: InterventionalSponsor: Evommune, Inc.Updated: Jul 1, 2026Locations: 14
Eligibility criteria
Adults aged 18 to <65 years [+3]
Difficulty distinguishing migraine from other headache types or presence of othe... [+2]